J. Faye

发表

Molecular Characterization of the Microsomal Tamoxifen Binding Site*

M. Oulad-Abdelghani, G. Favre, M. Poirot, 2004, Journal of Biological Chemistry.

Alternative initiation of translation accounts for a 67/45 kDa dimorphism of the human estrogen receptor ERalpha.

J. Faye, F. Bayard, P. Barraillé, 1999, Biochemical and biophysical research communications.

Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor.

W. Bowen, M. Poirot, B. Kedjouar, 1999, Biochemical pharmacology.

Overexpression of the FGF‐2 24‐kDa isoform up‐regulates IL‐6 transcription in NIH‐3T3 cells

J. Faye, F. Bayard, E. Arnaud, 1998, FEBS letters.

Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture.

G. Delsol, J. Faye, N. Blaes, 1995, Endocrinology.

17β-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice

J. Arnal, J. Faye, C. Fiévet, 1997 .

Oestrogen synthesis, oestrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells.

G. Delsol, J. Faye, N. Blaes, 1995, Ciba Foundation symposium.

Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways

G. Favre, F. Dalenc, M. Poirot, 2005, Breast Cancer Research.

Chemical-Based Translational Induction of Luciferase Expression: An Efficient Tool for in Vivo Screening of Protein Farnesylation Inhibitors

G. Favre, J. Faye, S. Vagner, 2005, Molecular Pharmacology.

Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells.

J. Carroll, R. Sutherland, S. Sebti, 2003, Endocrinology.

Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.

G. Favre, J. Faye, P. Balaguer, 2018 .

Prenylation inhibitors stimulate both estrogen receptor α transcriptional activity through AF-1 and AF-2 and estrogen receptor β transcriptional activity

P. Rochaix, G. Favre, J. Faye, 2004, Breast Cancer Research.

Characterization of a benzyl-phenoxy-ethanamine binding protein in Trypanosoma equiperdum and the possible relation between binding affinity and trypanocidal activity.

J. Périé, M. Poirot, J. Faye, 1993, Molecular and biochemical parasitology.

Production of monoclonal antibodies to human estrogen‐receptor protein (ER) using recombinant ER (RER)

J. Coindre, G. Delsol, H. Prats, 1993, International journal of cancer.

Characterization of the membranous antiestrogen binding protein: II. Purification to homogeneity.

M. Poirot, J. Faye, F. Bayard, 1994, Journal of receptor research.

RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: evidenced in vivo by an anti-farnesyl cysteine antibody.

G. Favre, J. Faye, C. Allal, 2000, Proceedings of the National Academy of Sciences of the United States of America.

A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer

J. Nicolas, F. Dalenc, J. Faye, 2004, Clinical chemistry and laboratory medicine.

Synthesis and application of a N-1' fluorescent biotinyl derivative inducing the specific carboxy-terminal dual labeling of a novel RhoB-selective scFv.

G. Favre, J. Faye, C. Blonski, 2009, Bioconjugate chemistry.

Preferential Transfer of Certain Plasma Membrane Proteins onto T and B Cells by Trogocytosis

G. Favre, J. Faye, E. Joly, 2010, PloS one.

Generation of a Single Chain Antibody Variable Fragment (scFv) to Sense Selectively RhoB Activation

G. Favre, L. Ligat, J. Faye, 2014, PloS one.

Characterization of the membranous antiestrogen binding protein: I. Partial purification of the protein in its active state.

M. Poirot, J. Faye, F. Bayard, 1994, Journal of receptor research.

Insulin and estrogen receptor ligand influence the FGF-2 activities in MCF-7 breast cancer cells.

M. Poirot, J. Faye, M. Rio, 2003, Biochemical pharmacology.

Identification of two tamoxifen target proteins by photolabeling with 4-(2-morpholinoethoxy)benzophenone.

P. Ferrara, M. Poirot, J. Faye, 2002, Bioconjugate chemistry.

Solubilization of a tamoxifen-binding protein. Assessment of its molecular mass.

J. Faye, M. le Maire, F. Bayard, 1988, The Biochemical journal.

Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS).

J. Périé, M. Poirot, P. de Medina, 2000, Bioorganic & medicinal chemistry.

Study of a Glycoprotein Produced by the Rat Epididymis

J. Faye, F. Bayard, M. Mazzuca, 1981 .

Purification, radioimmunoassay, and immunohistochemical localization of a glycoprotein produced by the rat epididymis.

J. Faye, F. Bayard, M. Mazzuca, 1980, Biology of reproduction.

Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats.

J. Faye, F. Bayard, A. Fargin, 1986, Endocrinology.

Different interaction of estradiol and antiestrogens with the estrogen receptor of rat uterus

J. Faye, F. Bayard, A. Fargin, 1986, Molecular and Cellular Endocrinology.

Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line

J. Faye, F. Bayard, M. Pichon, 1988, Molecular and Cellular Endocrinology.

Differential estrogenic responsiveness of MCF-7 cells. Relationship to the presence of two different estrogen receptors.

C. Toulas, J. Faye, F. Bayard, 1989, Journal of receptor research.

Tamoxifen Is a Potent Inhibitor of Cholesterol Esterification and Prevents the Formation of Foam Cells

G. Favre, M. Poirot, S. Silvente-Poirot, 2004, Journal of Pharmacology and Experimental Therapeutics.

Cytosolic type II estrogen binding site in rat uterus: specific photolabeling with estrone.

M. Poirot, J. Faye, F. Bayard, 1992, Journal of receptor research.

Characterization of estrogen binding sites in the liver of the newt Pleurodeles waltl (Urodela:Amphibia): demonstration of a sex-linked heterogeneity.

J. Faye, H. Dupont, C. Cayrol, 1986, Journal of steroid biochemistry.

Additive effects of tamoxifen and the farnesyl transferase inhibitor FTI‐277 on inhibition of MCF‐7 breast cancer cell‐cycle progression

R. Sutherland, G. Favre, J. Faye, 2003, International journal of cancer.

Use of phage display for the identification of molecular sensors specific for activated Rho.

G. Favre, J. Faye, P. Chinestra, 2012, Methods in molecular biology.

Identification of a GTP-bound Rho specific scFv molecular sensor by phage display selection

G. Favre, J. Faye, P. Chinestra, 2008, BMC biotechnology.

A potent and selective photoaffinity probe for the anti-estrogen binding site of rat liver.

M. Poirot, J. Faye, F. Bayard, 1990, The Journal of biological chemistry.

Presence of low affinity estrogen binding sites in guinea-pig Kurloff cells.

J. Izard, J. Darbon, J. Faye, 1988, Journal of steroid biochemistry.

Physicochemical and genetic evidence for specific antiestrogen binding sites.

E. Baulieu, J. Faye, F. Bayard, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Antiestrogen specific, high affinity saturable binding sites in rat uterine cytosol.

J. Faye, F. Bayard, B. Lasserre, 1980, Biochemical and biophysical research communications.

Temporal Logic Modeling of Biological Systems

Luis Fariñas del Cerro, Jean-Marc Alliot, Robert Demolombe, 2016, Towards Paraconsistent Engineering.

Further evidence for a biological role of anti-estrogen-binding sites in mediating the growth inhibitory action of diphenylmethane derivatives.

J. Périé, M. Poirot, J. Faye, 1988, Chemico-biological interactions.

Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity.

M. Poirot, B. Kedjouar, J. Faye, 1999, Biochemical pharmacology.

Expression of estrogen receptors during growth of human pancreatic adenocarcinoma cells (Capan-1)-relationship with differentiation

J. Faye, E. Hollande, M. Fanjul, 1998, In Vitro Cellular & Developmental Biology - Animal.

Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions.

J. Faye, J. Tauber, F. Bayard, 1985, Biochemical and biophysical research communications.

Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules

G. Favre, J. Faye, A. Tilkin-Mariamé, 2004, Cancer Gene Therapy.

DIFFERENTIAL ESTROGENIC RESPONSIVENESS OF RELATIONSHIP TO THE PRESENCE OF TWO DIFFERENT ESTROGEN RECEPTORS MCF-7 CELLS

C. Toulas, J. Faye, F. Bayard, 1989 .

RhoB Promotes γH2AX Dephosphorylation and DNA Double-Strand Break Repair

G. Favre, O. Sordet, J. Faye, 2014, Molecular and Cellular Biology.

TcRho1, a Farnesylated Rho Family Homologue from Trypanosoma cruzi

M. Gelb, F. Buckner, R. Baron, 2001, The Journal of Biological Chemistry.

Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding site.

P. Ferrara, M. Poirot, B. Kedjouar, 1998, The Biochemical journal.

Synthesis of estradiol-pheophorbide a conjugates: evidence of nuclear targeting, DNA damage and improved photodynamic activity in human breast cancer and vascular endothelial cells

J. Faye, J. Souchard, A. Noirot, 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

Detection of label-free cancer biomarkers using nickel nanoislands and quartz crystal microbalance

C. Vieu, G. Favre, J. Faye, 2010, International journal of nanomedicine.

[Identification of the beta lactamase R-TEM of Pseudomonas aeruginosa].

J. Faye, A. Philippon, R. Labia, 1975, Biochimie.

Interactions between trypanocidal drugs and membrane phospholipids. A surface pressure, surface potential and electrophoretic mobility study.

J. Périé, J. Faye, J. Tocanne, 1991, Biochemical pharmacology.

Estrogens modulate bovine vascular endothelial cell permeability and HSP 25 expression concomitantly.

J. Faye, F. Bayard, S. Daunes, 1998, American journal of physiology. Heart and circulatory physiology.

Estrogens modulate bovine vascular endothelial cell permeability and HSP 25 expression concomitantly

J. Faye, F. Bayard, S. Daunes, 1998 .

Cloning of the human RHOB gene promoter: characterization of a VNTR sequence that affects transcriptional activity.

G. Favre, J. Faye, Daniel Tovar, 2003, Genomics.

Geranylgeranyl transferase inhibition stimulates antimelanoma immune response through MHC class I and costimulatory molecule expression

G. Favre, J. Faye, G. Sarrabayrouse, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

, and DNA Double-Strand Break Repair H 2 AX Dephosphorylation γ RhoB Promotes

G. Favre, O. Sordet, J. Faye, 2014 .

The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.

M. Wilson, M. Poirot, J. Faye, 1990, Biochemical pharmacology.

17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice.

J. Arnal, J. Faye, C. Fiévet, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Pharmacological‐based translational induction of transgene expression in mammalian cells

G. Favre, J. Faye, S. Vagner, 2004, EMBO reports.

Radiation inactivation of estrogen receptor in intact human breast cancer cells (MCF‐7) Lack of energy transfer to the estradiol binding domain

C. Toulas, J. Faye, F. Bayard, 1991, FEBS letters.

Antiestrogens, different sites of action than the estrogen receptor?

J. Faye, F. Bayard, A. Fargin, 1987, Hormone research.